Nature: mRNA printers kick-start personalized medicines for all

GreenLight Biosciences has been profiled in Nature Biotechnology magazine as a pioneer of mRNA printers, which can produce low-cost vaccines and made-to-order treatments for a range of different diseases.

Greenlight Biosciences uses cell-free microbial lysates to manufacture mRNA. The company has adapted its inexpensive small interfering RNA production technology for insect and fungal pathogen control in agriculture and apiculture to human health applications. “We use microbial strains to produce the building blocks of RNA,” says cofounder and CEO Andrey Zarur.

Read the full article here.

Find out more about how GreenLight manufactures RNA.